期刊文献+

非分泌型CXCL16在乳腺癌细胞系中的表达及对其生物学特性的影响 被引量:4

Expression of Non-secretory CXCL16 and Its Impact on Biological Characteristics in Breast Cancer Cell Lines
原文传递
导出
摘要 目的通过检测非分泌型CXCL16在不同侵袭性乳腺癌细胞系(SK-BR-3、MCF-7、MDA-MB-231、MDA-MB-435S)及正常乳腺上皮细胞MCF-10A的表达,探讨非分泌型CXCL16表达对乳腺癌细胞生物学特性的影响。方法采用RT-PCR检测CXCL16mRNA在MCF-10A、SK-BR-3、MCF-7、MDA-MB-231、MDA-MB-435S细胞系的表达,将pEGFP-CXCL16真核表达质粒转染到低表达CXCL16的MDA-MB-231细胞,通过实时荧光定量PCR和Western blot验证CXCL16过表达,采用体外迁移、侵袭实验及甲基四唑蓝(MTT)法分别检测过表达CXCL16对MDA-MB-231细胞迁移、侵袭和增殖活性的影响。结果 CXCL16mRNA在高侵袭性的MDA-MB-231细胞低表达,在低侵袭性的MCF-7细胞高表达,过表达CXCL16使得MDA-MB-231细胞的迁移、侵袭减弱,而增殖未受到影响。结论非分泌型CXCL16表达与乳腺癌细胞系的侵袭性相关,其表达可以抑制乳腺癌细胞的体外迁移、侵袭。 Objective To detect the expression of non-secretory CXCL16 and its impact on malignant biological behaviors in breast cancer cell lines. Methods RT-PCR was carried out to examine the expression of CXCL16 mRNA in breast cancer cell lines with different aggressiveness SK-BR-3, MCF-7, MDA-MB-231, MDA- MB-435S and human mammary normal epithelial celll MCF-10A. The eukaryotic expression plasmid of CXCL16 was transfected into MDA-MB-231 ceils and overexpression of CXCL16 was confirmed by Real time PCR and Western blot. Boyden Chamber assay was used to determine cell migration and invasion, while MTT assay was performed to determine cell proliferation. Results Among four breast cancer cell lines, CXCL16 mRNA was highly expressed in MCF-7, lowly expressed in MDA-MB-231, while MCF-IOA faintly expressed CXCL16. Overexpression of CXCL16 led to a decrease in cell migration, invasion but not proliferation in MDA-MB-231 cells. Conclusion Expression of non-secretory CXCL16 is associated with aggressiveness of breast cancer cell lines, and CXCL16 expression inhibits cell migration and invasion in vitro.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2013年第4期522-525,530,共5页 Journal of Sichuan University(Medical Sciences)
基金 四川省科技支撑计划项目(No.2009SZ0146)资助
关键词 CXCL16 MDA—MB-231 迁移 侵袭 增殖 CXCL16 MDA-MB-231 Migration Invasion Proliferation
  • 相关文献

参考文献8

  • 1Matloubian M, David A, Engel S, etal. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol , 2000;1(4),298-304.
  • 2Zlotnik A, Burkhardt AM, Homey B. Homeostatic chemokine receptors and organ-specific metastasis. Nat Rev Immunol , 2011;11(9),597-606.
  • 3Lu Y , Wang J, Xu Y, et al. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro. Mol Cancer Res,2008,6(4) ,546-554.
  • 4Hojo S, Koizumi K, Tsuneyama K, etal. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer. Cancer Res, 2007,67 cio: ,4725-4731.
  • 5Gutwein P, Schramme A, Sinke N, et al. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients. Eur J Cancer, 2009, 45 ( 3) , 478- 489.
  • 6Wang J, Lu Y, Koch AE, et al. CXCR6 induces prostate cancer progression by the AKT /mammalian target of rapamycin signaling pathway. Cancer Res, 2008,68(24) ,10367-10376.
  • 7Ludwig A, Hundhausen C, Lambert MH, et al. Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAMI0 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb Chern High Throughput Screen,2005, 8(2) ,161-171.
  • 8Davison Z, de Blacquier e GE, Westley BR, et al. Insulin-like growth factor-dependent proliferation and survival of triple?negative breast cancer cells, implications for therapy. Neoplasia, 2011; 13(6) ,504-515.

同被引文献26

  • 1Ji-Ye Kee,Aya Ito,Shozo Hojo,Isaya Hashimoto,Yoshiko Igarashi,Kazuhiro Tsukada,Tatsuro Irimura,Naotoshi Shibahara,Takashi Nakayama,Osamu Yoshie,Hiroaki Sakurai,Ikuo Saiki,Keiichi Koizumi.Chemokine CXCL16 suppresses liver metastasis of colorectal cancer viaaugmentation of tumor-infiltrating natural killer T cells in a murine model[J].Oncology Reports.2013(3)
  • 2Gu Li,Kirsten Hattermann,Rolf Mentlein,H. Mehdorn,Janka Held-Feindt.The transmembrane chemokines CXCL16 and CX3CL1 and their receptors areexpressed in human meningiomas[J].Oncology Reports.2013(2)
  • 3Kohei Matsushita,Yuji Toiyama,Koji Tanaka,Susumu Saigusa,Junichiro Hiro,Keiichi Uchida,Yasuhiro Inoue,Masato Kusunoki.Soluble CXCL16 in Preoperative Serum is a Novel Prognostic Marker and Predicts Recurrence of Liver Metastases in Colorectal Cancer Patients[J].Annals of Surgical Oncology.2012(3)
  • 4Hong Ha,Wan Lee,Hyun Park,Sang Lee,Jeong Lee,Moon Chung.Clinical significance of CXCL16/CXCR6 expression in patients with prostatecancer[J].Molecular Medicine Reports.2011(3)
  • 5JankaHeld‐Feindt,BrigitteRehmke,RolfMentlein,KirstenHattermann,FriederikeKnerlich,Heinz‐HermannHugo,AndreasLudwig,H. MaximilianMehdorn.Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas[J].Glia.2008(7)
  • 6Hitoshi Hanamoto,Takashi Nakayama,Hajime Miyazato,Sumio Takegawa,Kunio Hieshima,Yoichi Tatsumi,Akihisa Kanamaru,Osamu Yoshie.Expression of CCL28 by Reed-Sternberg Cells Defines a Major Subtype of Classical Hodgkin’s Disease with Frequent Infiltration of Eosinophils and/or Plasma Cells[J].The American Journal of Pathology.2004(3)
  • 7Dick W?gs?ter,Anders Hugander,Jan Dimberg.Expression of CXCL16 in human rectal cancer[J].International Journal of Molecular Medicine.2004(1)
  • 8周雯慧,胡卫东,吴洲清,郑新民,汪必成.趋化因子轴CXCL16/CXCR6在人前列腺癌转移中的作用[J].中华医学杂志,2010,90(14):947-951. 被引量:8
  • 9周雯慧,胡卫东,徐闻博.趋化因子及其受体CXCL16/CXCR6体外促前列腺癌增殖、侵袭作用[J].武汉大学学报(医学版),2010,31(4):479-482. 被引量:2
  • 10孙琳,刘湘源,赵金霞,满斯亮,张霞.Raf/MEK/ERK信号通路对CXCL16诱导的CIA淋巴细胞增殖的影响[J].军医进修学院学报,2010,31(11):1113-1115. 被引量:4

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部